4//SEC Filing
LINDAHL RICHARD S 4
Accession 0001367644-24-000008
CIK 0001367644other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:26 PM ET
Size
7.0 KB
Accession
0001367644-24-000008
Insider Transaction Report
Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2024-02-21$2.71/sh−4,012$10,873→ 168,980 total - Tax Payment
Common Stock
2024-02-23$2.74/sh−517$1,417→ 168,463 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. On February 21, 2024, the final certification date, the Compensation Committee certified the achievement of the 2021-2023 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 4,012 shares previously reported on February 24, 2021.
- [F2]Represents shares of common stock withheld to pay taxes.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001196632
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 8:26 PM ET
- Size
- 7.0 KB